Peter Philip Lankhorst

This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Dsm IP Assets B.v., Dsm Sinochem Pharmaceuticals Netherlands B.v.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Philip Lankhorst. Retrieved from https://idiyas.com/inventor/peter-philip-lankhorst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 5)

% Patents Active = 90.0

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

Dsm Sinochem Pharmaceuticals Netherlands B.v.

patents

Years Active: 2017-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275755 - All-trans polyene amphoteric macrolide (2025-04-14),

2. 12202853 - Epoxide polyene amphoteric macrolide and process for purifying natamycin (2025-01-21),

3. 11623939 - All-trans polyene amphoteric macrolide (2023-04-11),

4. 11591360 - Epoxide polyene amphoteric macrolide and process for purifying natamycin (2023-02-28),

5. 11540544 - Steviol glycosides (2023-01-03),

6. 11344051 - Steviol glycosides (2022-05-31),

7. 10858683 - Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase (2020-12-08),

8. 10786000 - Process to produce a yeast-derived product comprising reducing sugar (2020-09-29),

9. 10392639 - Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase (2019-08-27),

10. 9556233 - Cyclohexapeptide (2017-01-31),

Title: The Innovations of Peter Philip Lankhorst

Introduction

Peter Philip Lankhorst is a notable inventor based in Echt, Netherlands. He has made significant contributions to the field of macrolide compounds, holding a total of 10 patents. His work focuses on the purification and development of polyene amphoteric macrolides, which have important applications in various industries.

Latest Patents

Lankhorst's latest patents include the "All-trans polyene amphoteric macrolide," which is directed to a process for purifying natamycin. This invention also encompasses a composition comprising the polyene amphoteric macrolide and a process for preparing it. Another significant patent is the "Epoxide polyene amphoteric macrolide and process for purifying natamycin," which similarly focuses on the purification of natamycin and the development of an epoxide polyene amphoteric macrolide.

Career Highlights

Throughout his career, Lankhorst has worked with prominent companies such as DSM IP Assets B.V. and DSM IP Assets B.V. His expertise in the field has allowed him to contribute to innovative solutions in the pharmaceutical and agricultural sectors.

Collaborations

Lankhorst has collaborated with notable professionals, including Alexander Lucia Leonardus Duchateau and Willebrordus Bernardus Van Scheppingen. These collaborations have further enhanced his research and development efforts.

Conclusion

Peter Philip Lankhorst's contributions to the field of macrolide compounds through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to impact various industries positively.

Profile summary based on public USPTO records.